Does Microalbuminuria has Positive Predictive Value in Patients With Essential Hypertension for Renovascular Hypertension?

Abstract

Background: Renovascular disease is an important correctable cause of secondary hypertension. We aimed to research whether microalbuminuria might be an indicator for renovascular hypertension among the essential hypertensive patients. Method: 330 essential hypertensive patients were enrolled to the study. Patients were divided into 2 groups: group 1 (microalbuminuria) and group 2 (normoalbuminuria). Urine albumin concentrations were measured by nepholometry after 24-hour urine collection. All subjects were examined by renal duplex doppler ultrasonography and who had renal artery stenosis then MR angiography was performed. Results: Microalbuminuria was detected in 107 of 330 essential hypertensive patients (32.42%). Mean CrCl levels (108,14±19,83 vs 116,36±18,62, p=0,002) were significantly lower in the group of patients with microalbuminuria. 3/107 (2.80%) of the patients had renal artery stenosis in the group of patients with microalbuminuria and 8/223 (3.58%) of the patients had renal artery stenosis in the group of patients with normoalbuminuria. This study showed a sensitivity of 2.8%, specificity 96.41%, positive predictive value 27.27%, negative predictive value 67.40%. Conclusion: We suggest that microalbuminuria isn’t an indicator for renovascular hypertension in patients with essential hypertension.

Keywords

• Renovascular hypertension, essential hypertension, microalbuminuria, renal doppler ultrasonography

References

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. (2005) Global burden of hypertension: analysis of worldwide data. Lancet, 365(9455):217–223.
2. Safian RD, Textor SC. (2001) Renal-artery stenosis. N Engl J Med, 344:431.
3. Davis BA, Crook JE, Vestal RE, Oates JA. (1979) Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. N Engl J Med, 301:1273.
4. Mann SJ, Pickering TG. (1992) Detection of renovascular hypertension. State of the art, Ann Intern Med, 117:845.
5. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM. (2001) Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med. ;135(6):401-11.
6. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al. (2006) ACC/AHA 2005 Practice
7. Guidelines for the management of patients with peripheral arterial disease Circulation, 113:e463. Mogensen CE. (1995) Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin-dependent diabetes mellitus patients. J Diabetes Complicat, 9: 337–49.
8. Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M et al. (2005) Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess. 9(30):160 -163.

9. Parving HH, Mogensen CE, Jensen HA, Evrin PE. (1974) Increased urinary albumin-excretion rate in benign essential hypertension. Lancet, 1:1190–1192.
10. Cerasola G, Cottone S, D'Ignoto G, Grasso L, Mangano MT, Carapelle E et al. (1989) Microalbuminuria as a predictor of cardiovascular damage in essential hypertension. J Hypertens Suppl, 7:S332-S333.
11. Bigazzi R, Bianchi S, Campese VM, Baldari G. (1992) Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron.61(1):94–7.
12. Mogensen CE. (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med.310:356 –360.
13. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ et al. (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation.106:1777–1782.
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 289(19):2560–2572.
15. World Health Report. (2002) Reducing risks, promoting healthy life. Geneva, Switzerland:World Health
16. Organization, http:// www.who.int/whr/2002.
17. Derkx FH, Schalekamp MA. (1994) Renal artery stenosis and hypertension. Lancet.344:237-9.
18. Eardley KS, Lipkin GW. (1999) Atherosclerotic renal artery stenosis: is it worth diagnosing? J Hum Hypertens.13:217-20.
19. Winocour PH, Harland JO, Millar JP, Laker MF, Alberti KG. (1992) Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis.93:71– 81.
20. Horner D, Fliser D, Klimm HP, Ritz E. (1996) Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners. J Hypertens.14:655– 660.
21. Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R et al. (1998) Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: the Gubbio Population
22. Study. Arch Intern Med.158: 1933–1939.
23. Crippa G. (2002) Microalbuminuria in essential hypertension Journal of Human Hypertension. 16 Suppl 1:S74–7.
24. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed- Enevoldsen A. (1989) Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia.32:219 –226
25. Böhm M, Thoenes M, Danchin N, Bramlage P, La Puerta P, Volpe M. (2007) Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study. J Hypertens. 25(11):2317–24.
26. Shantha GP, Kumar AA, Bharadhi MK, Arthur P. (2009) Role of gender in the associations of microalbuminuria with inflammatory markers in hypertensive subjects: a cross-sectional study. Kidney Blood Press Res.32(6):434–9.
27. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A et al. (1997) Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on
28. Complications. Hypertension. 30(5):1135–43.
29. Bibek Poudel, Binod Kumar Yadav, Ashwini Kumar Nepal, Bharat Jha, and Kanak Bahadur Raut. (2012) Prevalence and Association of Microalbuminuria in Essential Hypertensive Patients. N Am J Med Sci. August; 4(8): 331–3
30. Valensi P, Assayag M, Busby M, Pariès J, Lormeau B, Attali JR. (1996) Int J Obes Relat Metab Disord. 20(6): 574-9.
31. Microalbuminuria in obese patients with or without hypertension Nakamura M, Onoda T, Itai K, Ohsawa M, Satou K, Sakai T et al. (2004) Association between serum C-reactive protein levels and microalbuminuria: a populationbased cross-sectional study in northern Iwate, Japan. Intern Med. 43: –25.
32. Kshirsagar AV, Bomback AS, Bang H, Gerber LM, Vupputuri S, Shoham DA et al. (2008) Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004). Am J Cardiol. 101: 401–406
33. Spoelstra-de Man AME, Brouwer CB, Stehouwer CDA, Smulders YM. (2001) Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria. Diabetes Care. 24: 2097–101.
34. Stehouwer CDA, Gall M-A, Twisk JWR, Knudsen E, Emeis JJ, Parving HH. (2002) Increased urinary albumin excretion, endothelial dysfunction and chronic low-grade inflammation in type 2 diabetes. Progressive, interrelated, and independently associated with risk of death. Diabetes. 51: 1157–65.
35. Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM et al. (2001) Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria.
36. Nephrol Dial Transplant. 16: 529–36. Spijkerman AM, Adriaanse MC, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM et al. (2002) Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care. 25: –24.
37. Festa A, D’Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. (2000) Inflammation and microalbuminuria in non-diabetic and type 2 diabetic subjects: The Insulin Resistance Atheroschlerosis Study. Kidney Int. 58: 1703–10.